Clinicopathological significance of hypoxia-inducible factor-1 alpha polymorphisms in cancers: evidence from a meta-analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological significance of hypoxia-inducible factor-1 alpha polymorphisms in cancers: evidence from a meta-analysis
Authors
Keywords
Clinicopathological, HIF-1α, Polymorphisms, Cancers, Meta-analysis
Journal
TUMOR BIOLOGY
Volume 34, Issue 5, Pages 2477-2487
Publisher
Springer Nature
Online
2013-07-15
DOI
10.1007/s13277-013-0971-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population
- (2012) Pu Li et al. ASIAN JOURNAL OF ANDROLOGY
- HIF1AC1772T polymorphism leads to HIF-1α mRNA overexpression in prostate cancer patients
- (2012) Michael Vainrib et al. CANCER BIOLOGY & THERAPY
- Polymorphisms in HIF-1alpha affect presence of lymph node metastasis and can influence tumor size in squamous-cell carcinoma of the glottic larynx
- (2012) F. Mera-Menéndez et al. Clinical & Translational Oncology
- Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer
- (2012) Taro Isobe et al. International Journal of Clinical Oncology
- The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma
- (2011) C. Qin et al. ANNALS OF ONCOLOGY
- Polymorphisms in the hypoxia-inducible factor-1α gene confer susceptibility to pancreatic cancer
- (2011) Xiuchao Wang et al. CANCER BIOLOGY & THERAPY
- Hypoxia-Inducible Factor-1 Alpha C1772T Gene Polymorphism and Glioma Risk: A Hospital-Based Case–Control Study from China
- (2011) Gaofeng Xu et al. Genetic Testing and Molecular Biomarkers
- A high HIF-1α expression genotype is associated with poor prognosis of upper aerodigestive tract carcinoma patients
- (2011) Carlos Alberto de Carvalho Fraga et al. ORAL ONCOLOGY
- Association of hypoxia inducible factor-1α polymorphisms with susceptibility to non–small-cell lung cancer
- (2011) Wu-Hsien Kuo et al. Translational Research
- Hypoxia-Inducible Factor 1α Polymorphisms and Early-Stage Cervical Cancer
- (2010) Yun Hwan Kim et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Hypoxia inducible factor-1α gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma
- (2010) Pei-Ching Hsiao et al. JOURNAL OF SURGICAL ONCOLOGY
- No association of the hypoxia-inducible factor-1α gene polymorphisms with survival in patients with colorectal cancer
- (2010) Soo Jung Lee et al. MEDICAL ONCOLOGY
- Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1α and the clinicopathological features of oral squamous cell carcinoma
- (2010) Tzong-Ming Shieh et al. ORAL ONCOLOGY
- Polymorphisms in the Hypoxia Inducible Factor 1-α and the Impact on the Prognosis of Early Stages of Oral Cancer
- (2009) Mario Fernando Muñoz-Guerra et al. ANNALS OF SURGICAL ONCOLOGY
- HIF-1: upstream and downstream of cancer metabolism
- (2009) Gregg L Semenza CURRENT OPINION IN GENETICS & DEVELOPMENT
- Associations between hypoxia-inducible factor-1α (HIF-1α) gene polymorphisms and risk of developing breast cancer
- (2009) R. NAIDU et al. NEOPLASMA
- Single Nucleotide Polymorphisms in the Hypoxia-inducible Factor-1α (HIF-1α) Gene in Human Sporadic Breast Cancer
- (2008) Isil Apaydin et al. ARCHIVES OF MEDICAL RESEARCH
- Rare variant of hypoxia-inducible factor-1α (HIF-1A) and breast cancer risk in Korean women
- (2008) Ji-Young Lee et al. CLINICA CHIMICA ACTA
- Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis
- (2008) Masataka Uehara et al. ORAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now